FAAH and Parkinson disease: For example, mutations in the SCN9A (sodium channel Nav1.7) and FAAH (fatty acid amide hydrolase, a key cannabinoid metabolizing enzyme) genes have been associated with higher susceptibility to this symptom in PD [43, 44].